Mihael Polymeropoulos, Vanda Pharmaceuticals CEO
Vanda appeals to FDA again, insisting on sNDA hearing in latest wrinkle in jet lag drug saga
Just over a month after CDER director Patrizia Cavazzoni made clear that she and FDA were looking to shut down Vanda Pharmaceuticals’ sNDA request, the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.